Jiankang Jin

1.4k total citations
23 papers, 644 citations indexed

About

Jiankang Jin is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jiankang Jin has authored 23 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cell Biology and 5 papers in Oncology. Recurrent topics in Jiankang Jin's work include Hippo pathway signaling and YAP/TAZ (6 papers), Virus-based gene therapy research (5 papers) and Cancer-related gene regulation (5 papers). Jiankang Jin is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (6 papers), Virus-based gene therapy research (5 papers) and Cancer-related gene regulation (5 papers). Jiankang Jin collaborates with scholars based in United States, China and Japan. Jiankang Jin's co-authors include Jaffer A. Ajani, Shumei Song, Ailing W. Scott, Randy L. Johnson, Lang Ma, Heath D. Skinner, Qiongrong Chen, Soichiro Honjo, Tsung‐Teh Wu and Neda Kalhor and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Jiankang Jin

22 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiankang Jin United States 12 377 297 194 89 76 23 644
Joanna Obacz United States 12 311 0.8× 327 1.1× 86 0.4× 116 1.3× 77 1.0× 15 610
Travis J. Yates United States 14 439 1.2× 217 0.7× 193 1.0× 183 2.1× 88 1.2× 21 717
Daiana L. Vitale Argentina 12 293 0.8× 191 0.6× 100 0.5× 105 1.2× 53 0.7× 20 447
Cheryl McFarlane United Kingdom 14 460 1.2× 132 0.4× 246 1.3× 128 1.4× 102 1.3× 19 680
ZhengMing Wu United States 9 469 1.2× 274 0.9× 304 1.6× 144 1.6× 235 3.1× 16 868
Diogo O. Escudero United States 7 279 0.7× 207 0.7× 106 0.5× 82 0.9× 60 0.8× 8 439
Lauren B. Tolliver United States 8 350 0.9× 187 0.6× 152 0.8× 56 0.6× 66 0.9× 8 484
Ravi Chakra Turaga United States 14 224 0.6× 126 0.4× 141 0.7× 90 1.0× 53 0.7× 16 408
Rhonda L. Brown United States 6 516 1.4× 175 0.6× 293 1.5× 188 2.1× 41 0.5× 6 743
Brigitte Bisarò Italy 12 307 0.8× 109 0.4× 172 0.9× 103 1.2× 51 0.7× 16 513

Countries citing papers authored by Jiankang Jin

Since Specialization
Citations

This map shows the geographic impact of Jiankang Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiankang Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiankang Jin more than expected).

Fields of papers citing papers by Jiankang Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiankang Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiankang Jin. The network helps show where Jiankang Jin may publish in the future.

Co-authorship network of co-authors of Jiankang Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiankang Jin. A scholar is included among the top collaborators of Jiankang Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiankang Jin. Jiankang Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sewastjanow‐Silva, Matheus, Kohei Yamashita, Ahmed Abdelhakeem, et al.. (2024). Three biomarkers ( HER2 , PD‐L1 , and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience. International Journal of Cancer. 155(12). 2277–2286. 2 indexed citations
2.
Fan, Yibo, Melissa Pool Pizzi, Gengyi Zou, et al.. (2024). Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations. iScience. 28(1). 111564–111564. 2 indexed citations
3.
Yoshimura, Katsuhiro, Gengyi Zou, Yibo Fan, et al.. (2024). HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. Cancer Letters. 610. 217354–217354. 6 indexed citations
4.
Fan, Yibo, Shumei Song, Yuan Li, et al.. (2023). Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer Research. 83(22). 3726–3738. 22 indexed citations
5.
Jin, Jiankang, Katsuhiro Yoshimura, Matheus Sewastjanow‐Silva, Shumei Song, & Jaffer A. Ajani. (2023). Challenges and Prospects of Patient-Derived Xenografts for Cancer Research. Cancers. 15(17). 4352–4352. 45 indexed citations
6.
Jin, Jiankang, Longfei Huo, Yibo Fan, et al.. (2023). A new intronic quantitative PCR method led to the discovery of transformation from human ascites to murine malignancy in a mouse model. Frontiers in Oncology. 13. 1062424–1062424. 2 indexed citations
7.
Jin, Jiankang, Yan Xu, Longfei Huo, et al.. (2020). An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue. PLoS ONE. 15(2). e0228910–e0228910. 20 indexed citations
8.
Li, Yuan, Shumei Song, Melissa Pool Pizzi, et al.. (2020). LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma. Cancers. 12(10). 2995–2995. 14 indexed citations
9.
Song, Shumei, Zhenning Wang, Yuan Li, et al.. (2019). PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression. Molecular Cancer Research. 18(3). 390–402. 23 indexed citations
10.
Yang, Yiting, et al.. (2018). The prognostic significance of tumour-infiltrating lymphocytes and programmed death ligandexpression in patients with squamous cell carcinoma of bladder. European Urology Supplements. 17(2). e137–e137. 2 indexed citations
11.
Harada, Kazuto, Shumei Song, Yan Xu, et al.. (2018). Abstract 288: Genomic profiling of metastatic gastric adenocarcinoma. Cancer Research. 78(13_Supplement). 288–288. 1 indexed citations
12.
Jin, Jiankang, Longfei Huo, Shumei Song, & Jaffer A. Ajani. (2018). CRISPR/Cas9 Technology Improvements and the RNA- Editing Trend. 2(1). 1–1. 1 indexed citations
13.
Song, Shumei, Min Xie, Ailing W. Scott, et al.. (2017). A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma. Molecular Cancer Therapeutics. 17(2). 443–454. 141 indexed citations
14.
Song, Shumei, Soichiro Honjo, Jiankang Jin, et al.. (2015). The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer. Clinical Cancer Research. 21(11). 2580–2590. 200 indexed citations
15.
Panneerselvam, Janani, Manish Shanker, Jiankang Jin, et al.. (2015). Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity. Oncotarget. 6(18). 16271–16286. 14 indexed citations
16.
Panneerselvam, Janani, Jiankang Jin, Manish Shanker, et al.. (2015). IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis. PLoS ONE. 10(3). e0122439–e0122439. 60 indexed citations
17.
Chen, Qiongrong, Shumei Song, Shaozhong Wei, et al.. (2015). ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer. Oncotarget. 6(28). 25883–25896. 33 indexed citations
18.
Jin, Jiankang, Jie Chen, & Quanda Zhang. (2014). Analysis on the Impact of the Fluctuation of the International Gold Prices on the Chinese Gold Stocks. Discrete Dynamics in Nature and Society. 2014. 1–6. 1 indexed citations
19.
Panneerselvam, Janani, Manish Shanker, Jiankang Jin, et al.. (2013). Abstract 5249: Functional importance of IL-24 phosphorylation in regulating molecular signaling pathways associated with cancer cell survival and metastasis.. Cancer Research. 73(8_Supplement). 5249–5249. 2 indexed citations
20.
Kuroda, Shinji, Tomohisa Yokoyama, Justina Tam, et al.. (2012). Multifunctional Tumor-Targeted Nanoparticles for Lung Cancer. 15–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna Obacz Breakdown of academic impact, for papers by Travis J. Yates Breakdown of academic impact, for papers by Daiana L. Vitale Breakdown of academic impact, for papers by Cheryl McFarlane Breakdown of academic impact, for papers by ZhengMing Wu Breakdown of academic impact, for papers by Diogo O. Escudero Breakdown of academic impact, for papers by Lauren B. Tolliver Breakdown of academic impact, for papers by Ravi Chakra Turaga Breakdown of academic impact, for papers by Rhonda L. Brown Breakdown of academic impact, for papers by Brigitte Bisarò
Rankless by CCL
2026